Clinical Trials Browser

Phase 2 × tariquidar × Tumor-Agnostic × Clear all

NCT00082368 2017-08-17

PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy

Phase 2 Completed

12 enrolled 11 charts

Neoplasms